Cargando…
Serum levels of caspase-cleaved cytokeratin 18 (CK18-Asp396) predict severity of liver disease in chronic hepatitis B
BACKGROUND AND AIM: Caspase-cleaved cytokeratin 18 (CK18-Asp396) is a potential clinically useful biomarker in liver disease as it is released from hepatocytes during apoptosis. In this study, we investigated serum CK18-Asp396 levels in chronic hepatitis B (CHB). PATIENTS AND METHODS: Overall, 163 p...
Autores principales: | Li, Juan, Verhaar, Auke P, Pan, Qiuwei, de Knegt, Robert Jacobus, Peppelenbosch, Maikel P |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5560566/ https://www.ncbi.nlm.nih.gov/pubmed/28860836 http://dx.doi.org/10.2147/CEG.S135526 |
Ejemplares similares
-
The Significance of Caspase-Cleaved Cytokeratin 18 in Pleural Effusion
por: Lee, Keu Sung, et al.
Publicado: (2014) -
Chemotherapy increases caspase-cleaved cytokeratin 18 in the serum of breast cancer patients
por: Ulukaya, Engin, et al.
Publicado: (2011) -
High Serum Caspase-Cleaved Cytokeratin-18 Levels and Mortality of Traumatic Brain Injury Patients
por: Lorente, Leonardo, et al.
Publicado: (2019) -
Total and caspase-cleaved cytokeratin 18 in chronic cholecystitis: A prospective study
por: Simopoulos, Constantinos, et al.
Publicado: (2008) -
Serum Levels of Caspase-Cleaved Cytokeratin-18 and Mortality Are Associated in Severe Septic Patients: Pilot Study
por: Lorente, Leonardo, et al.
Publicado: (2014)